Faculty: Brian Duty, MD and Nicole Miller, MD
Moderator: Charles Scales, MD
Brian Duty, MD
Dr. Duty’s is an Associate Professor in the Department of Urology at Oregon Health & Science University (OHSU). His clinical and research interests are in minimally invasive surgery for kidney obstruction, stones and cancer. He also has expertise in preventing kidney stones through dietary and medical management. Dr. Duty attended OHSU for both medical school and residency. After his urologic residency training he went on to complete a fellowship at the Smith Institute for Urology in Long Island, New York.
Nicole Miller, MD
Dr. Nicole Miller currently holds the position of Professor of Urology at Vanderbilt University School of Medicine in Nashville, TN. She joined the department in 2007. She completed her M.D. degree at the University of Pittsburgh School of Medicine in 2000, and received her urology residency training at the University of Virginia. Dr. Miller went on to complete a 2 year fellowship in Endourology and Minimally Invasive Surgery at the Indiana University School of Medicine under the mentorship of Dr. James E. Lingeman. She specializes in the medical and surgical treatment of kidney stone disease as well as laser surgery for BPH. Dr. Miller’s research interests include investigation of Randall’s plaque in the pathophysiology of nephrolithiasis, new laser technologies for kidney stone and BPH treatment, novel platforms for BPH surgery and investigation of pathophysiologic pathways for refractory BPH/LUTS. She has been the major contributor of transition zone prostate tissues from men undergoing surgery for refractory BPH/LUTS as part of Vanderbilt University’s Biorepository in the Center for Benign Urologic Diseases (CBUD) and has co-authored work on this developing resource. She has served as course faculty member and moderator both nationally and internationally for the American Urological Association and Endourological Society in the area of surgical treatment of BPH and nephrolithiasis. Dr. Miller is an Editorial Board Member for the Journal of Urology, Journal of Endourology and Director of the Minimally Invasive Surgery and Endourology Fellowship at Vanderbilt University Medical Center. She also served as a member of the AUA guidelines panel for the Surgical Management of Nephrolithiasis and AUA Leadership Class of 2017.
Charles Scales, MD
Charles D. Scales, Jr., MD MSHS FACS is Associate Professor of Surgery and Population Health Science in the Division of Urologic Surgery at Duke University School of Medicine, and Director of the Duke Surgical Center for Outcomes Research & Equity in Surgery (SCORES). He completed medical school and residency training in urology at Duke University Medical Center. After residency, Dr. Scales completed the Robert Wood Johnson Foundation Clinical Scholars Program at UCLA, where he received advanced training in health services research, health policy, and quality of care.
Dr. Scales has a strong interest in medical education, having previously served on the ACGME Review Committee for Urology and as a member of the ACGME Board of Directors. He currently leads a course in quality improvement and data analytics in the Masters of Management in Clinical Informatics program at the Duke University School of Medicine.
From the research perspective, Dr. Scales has a longstanding interest in the epidemiology of and patient care for urinary stone disease. Recent studies have redefined the epidemiology of urinary stone disease in the United States, compared the effectiveness of dominant stone removal technologies, and identified new opportunities for improving patient-centered and policy-relevant outcomes, such as unplanned care after procedural interventions. His research and perspective on urinary stone disease has been highlighted in U.S. News & World Report, Reuters, NPR, and the Wall Street Journal, among other media outlets.
Currently, Dr. Scales leads a diverse health services and clinical research program at the Duke Clinical Research Institute, where he is the Principal Investigator for the Scientific Data and Research Center for the NIDDK Urinary Stone Disease Research Network (U01). Within the USDRN, he leads the multicenter Prevention of Urinary Stones with Hydration (PUSH) randomized clinical trial, and the multicenter Study to Enhance Understanding of Stent-Associated Symptoms (STENTS) cohort study.